Literature DB >> 14719844

Vulvovaginal candidiasis.

Paul Nyirjesy1, Jack D Sobel.   

Abstract

VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms. Future advances, particularly in the area of home diagnostics, may help to optimize use of currently available medicines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719844     DOI: 10.1016/s0889-8545(03)00083-4

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  10 in total

1.  Evaluating vaginitis. The importance of patient factors.

Authors:  Lisa L Willett; Robert M Centor
Journal:  J Gen Intern Med       Date:  2005-09       Impact factor: 5.128

2.  Group B streptococcus: prevalence in a non-obstetric population.

Authors:  Catherine M Leclair; Ashley E Hart; Martha F Goetsch; Heather Carpentier; Jeffrey T Jensen
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

Review 3.  [Mycotic infections of the anogenital region].

Authors:  P Mayser; W Hort; S Pflieger-Bruss
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

4.  Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates.

Authors:  Majid Zare-Bidaki; Anis Maleki; Nahid Ghanbarzadeh; Fatemeh Nikoomanesh
Journal:  Mol Biol Rep       Date:  2022-09-28       Impact factor: 2.742

5.  Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.

Authors:  Soledad Gamarra; Susana Morano; Catiana Dudiuk; Estefanía Mancilla; María Elena Nardin; Emilce de Los Angeles Méndez; Guillermo Garcia-Effron
Journal:  Mycopathologia       Date:  2014-07-09       Impact factor: 2.574

6.  Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan.

Authors:  Sarika P Kombade; Kumar S Abhishek; Payal Mittal; Charu Sharma; Pratibha Singh; Vijaya L Nag
Journal:  J Family Med Prim Care       Date:  2021-01-30

Review 7.  Studies of Immune Responses in Candida vaginitis.

Authors:  Flavia De Bernardis; Silvia Arancia; Silvia Sandini; Sofia Graziani; Sandro Norelli
Journal:  Pathogens       Date:  2015-10-09

8.  Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.

Authors:  Adane Bitew; Yeshiwork Abebaw
Journal:  BMC Womens Health       Date:  2018-06-15       Impact factor: 2.809

9.  A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro.

Authors:  Maciej Masłyk; Monika Janeczko; Oleg M Demchuk; Anna Boguszewska-Czubara; Hieronim Golczyk; Anna Sierosławska; Anna Rymuszka; Aleksandra Martyna; Konrad Kubiński
Journal:  Saudi Pharm J       Date:  2017-12-05       Impact factor: 4.330

Review 10.  Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives.

Authors:  Valentina Sustr; Philipp Foessleitner; Herbert Kiss; Alex Farr
Journal:  J Fungi (Basel)       Date:  2020-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.